Quadria Capital Fund is an investment fund in the health sector. It is planning to invest in healthcare centers, the pharmaceutical industry, medical technologies and healthcare services in South and Southeast Asia.
Quadria Capital Fund L.P. is an investment fund that specifically targets the health sector in South and Southeast Asia. It is the 3rd investment vehicle managed by the members of the Quadria Capital management team, that has a collective experience of investing over US$ 900 million in 14 companies across six countries in the region. The fund is managed by a Singapore based investment manager regulated by the Monetary Authority of Singapore.
Proparco’s equity investment is part of the fund’s second closing. Quadria Capital Fund plans to invest in four market segments: hospitals and clinics, the pharmaceutical industry, medical technologies and the related health services. It will primarily target India, Indonesia, Vietnam, the Philippines, Thailand and Malaysia. Its objective is to contribute to the development of healthcare provision by pursuing an investment strategy that aims to foster the emergence of regional players.
This operation will support the development of the hospital and pharmaceutical sectors in geographical areas that suffer from a lack of provision, and an improvement in the overall level of healthcare quality. It will also contribute to maintaining and creating employment with an expected payroll of some 20,000 people for all the companies in the portfolio. In addition, it will contribute to training health staff in South and Southeast Asia.